CMS posts final decision memo for PET

03/8/2013

On Thursday, March 7, the Centers for Medicare & Medicaid Services posted its final decision memo for PET. This reconsideration followed a letter from the Medical Imaging Technology Alliance requesting that CMS remove the current non-coverage language for new PET radiopharmaceuticals that receive approval from the Food and Drug Administration. CMS will allow local coverage options for oncologic indications of FDA-approved PET tracers after Sept. 1, 2013.

View Full Article in:

http://www.snmmi.org/index.cfm?PageID=12449%20

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX